Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.

about

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial.Current Review on High-Risk Multiple Myeloma.The evolution of stem-cell transplantation in multiple myeloma.[Multiple myeloma : What has been confirmed in therapy?]

P2860

Q38650700-D3588F58-CD5F-48E6-AF59-0F07D3697D16 Q38895167-10E93291-DBA6-494E-9C45-D28B8B4B3D0A Q52715329-641054DE-E17C-424C-AD70-FEE7951547BD Q52817414-7545E1B2-C8D7-4E3B-8398-28606F4D9C41

P2860

Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.

Item

http://www.wikidata.org/entity/Q40845932

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Single versus tandem high-dose ...... the phase III GMMG-HD2 trial.

@en

type

Item

label

Single versus tandem high-dose ...... the phase III GMMG-HD2 trial.

@en

prefLabel

Single versus tandem high-dose ...... the phase III GMMG-HD2 trial.

@en

P1476

Single versus tandem high-dose ...... the phase III GMMG-HD2 trial.

@en

P2093

Andreas Neubauer

http://www.w3.org/2001/XMLSchema#string

Annette Hänel

http://www.w3.org/2001/XMLSchema#string

Anthony D Ho

http://www.w3.org/2001/XMLSchema#string

Astrid Peyn

http://www.w3.org/2001/XMLSchema#string

Axel Benner

http://www.w3.org/2001/XMLSchema#string

Christof Scheid

http://www.w3.org/2001/XMLSchema#string

Gerlinde Egerer

http://www.w3.org/2001/XMLSchema#string

Jens Hillengass

http://www.w3.org/2001/XMLSchema#string

Kai Neben

http://www.w3.org/2001/XMLSchema#string

Norma Peter

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study.

Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences

A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

How we manage autologous stem cell transplantation for patients with multiple myeloma

Lenalidomide after stem-cell transplantation for multiple myeloma

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

How to establish equivalence when data are censored: a randomized trial of treatments for B non-Hodgkin lymphoma.

Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma.

Methods for equivalence and noninferiority testing.

P304

731-741

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.13994

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

173

http://www.w3.org/2001/XMLSchema#string

P50

Hartmut Goldschmidt

Marc S Raab

E K Mai

P577

2016-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26990892

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.

about

P2860

P2860

Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921